window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Medicines Discovery Catapult

  • Biotech & Pharma Business,Central Nervous System,Drug Discovery & Development

    Deep Science Ventures and Medicines Discovery Catapult target blood-brain barrier challenge

    Deep Science Ventures and Medicines Discovery Catapult have launched a [...]

    June 6, 2026
  • Biotech & Pharma Business,Pharmaceuticals and therapeutics

    BIA names Chris Molloy CEO to drive UK bioscience growth

    The BioIndustry Association (BIA) has appointed Chris Molloy as its [...]

    May 5, 2026
  • Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    UK nuclear materials to power new precision cancer therapies

    The UK is launching a major programme to convert used [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics

    PACE launches third funding round to tackle antimicrobial resistance and support innovative therapeutics

    PACE (Pathways to Antimicrobial Clinical Efficacy) has launched its third [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    New glioblastoma treatment project secures funding from The Brain Tumour Charity

    Medicines Discovery Catapult (MDC) and King’s College London (KCL) have [...]

    May 5, 2026
  • Uncategorised

    Selvita licenses Medicines Discovery Catapult’s target engagement technology

    Selvita has become the first contract research organisation (CRO) to [...]

    May 29, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • EMA accepts Almirall application to extend Ebglyss use in young children with atopic dermatitis
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Ten-year NHS study supports focal therapy for prostate cancer with fewer side effects
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Mission Therapeutics signs US$292M deal for acute kidney injury programme
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top